Since 2006 PolyCrystalLine collaborates with the Molecular Crystal Engineering (MCE) group at the Chemistry Department G. Ciamician of the Univer...
Read MoreIn less than a month we will take off to New York and take part to DCAT (Drug, Chemical & Associated Technologies Associa...
Read MoreAre we going to be present at the next CPhI in Frankfurt? We are, of course! For three days, from November 1st to 3rd, we have the opportunity to reaf...
Read MoreABOUT THE CH@BO n.11 ONLINE CONVENTION Because of the uncertainties still associated with the pandemic of SARS-COVID-19 the 11th edition of the Bologn...
Read MoreMeet us at the forthcoming CPhI 2021 in Milan, from November 9 to November 11. We will be at booth, 4H93, to introduce the latest development of...
Read MoreThe construction work of the new facility started in Mesagne (BR), Puglia in June 2021....
Read MoreThis is the render of PolycrystalLine’s new facility, dedicated to the new CDMO services, that will be located in Mesagne (BR), Puglia....
Read MoreNew Crystalline Forms of Des-Methyl-Venlafaxine Salt Discovered PolyCrystalLine s.r.l. and Segrub Pharmaceuticals have developed a gene...
Read MoreABSTRACT: The structure−property relationships of new polymorphs of the chiral herbicide imazamox were investigated by X-ray diffraction, hot s...
Read MoreWe invite you to join us at our booth n. 4H93 and learn more about our capabilities: In order to schedule a meeting please contact marco.glucini@...
Read MoreWe invite you to join us in our meeting room at the Intercontinental Suite #510/511 and learn more about our capabilities: In order to schedule a meet...
Read MoreNew Crystalline Forms of Dex-Lansoprazole Discovered PolyCrystalLine s.r.l. and Segrub Pharmaceuticals have developed a generic equivalent to Kap...
Read MorePolyCrystalLine discovered a novel crystalline form of Minodronic Acid and filed a patent application. For additional information contact info@po...
Read More